Details of the Drug Inactive Ingredient (DIG)
General Information of DIG (ID: E00FTX) | |||||
---|---|---|---|---|---|
DIG Name |
Gelatin
|
||||
DIG Function |
Other agent
|
||||
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Saquinavir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[1] | |||
Indinavir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[2] | |||
Simeprevir
|
API Info |
Viral hepatitis [ICD-11: 1E51]
|
[3] | |||
ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
Topotecan
|
API Info |
Ovarian cancer [ICD-11: 2C73]
|
[4] | |||
Panobinostat
|
API Info |
Multiple myeloma [ICD-11: 2A83]
|
[5] | |||
Niraparib
|
API Info |
Ovarian cancer [ICD-11: 2C73]
|
[6] | |||
Procarbazine
|
API Info |
Hodgkin lymphoma [ICD-11: 2B30]
|
[7] | |||
Nilotinib
|
API Info |
Chronic myelogenous leukaemia [ICD-11: 2A20]
|
[8] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Liothyronine
|
API Info |
Hypothyroidism [ICD-11: 5A00]
|
[9] | |||
Cysteamine
|
API Info |
Nephropathic cystinosis [ICD-11: 5C60]
|
[10] | |||
Trientine
|
API Info |
Hyperphosphatemia [ICD-11: 5C64]
|
[11] | |||
Eliglustat
|
API Info |
Gaucher disease [ICD-11: 5C56]
|
[12] | |||
Ixazomib
|
API Info |
Amyloidosis [ICD-11: 5D00]
|
[13] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Fluoxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[14] | |||
Venlafaxine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[15] | |||
Ziprasidone
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[16] | |||
Lithium carbonate
|
API Info |
Bipolar disorder [ICD-11: 6A60]
|
[17] | |||
Nortriptyline
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[18] | |||
Loxapine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[19] | |||
Chlordiazepoxide
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[20] | |||
Trimipramine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[21] | |||
Tranylcypromine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[22] | |||
Asenapine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[23] | |||
Cariprazine
|
API Info |
Bipolar disorder [ICD-11: 6A60]
|
[24] | |||
Naltrexone
|
API Info |
Alcohol dependence [ICD-11: 6C40]
|
[25] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Gabapentin
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[26] | |||
Tizanidine
|
API Info |
Tic disorder [ICD-11: 8A05]
|
[27] | |||
Methylergonovine
|
API Info |
Migraine [ICD-11: 8A80]
|
[28] | |||
Pentosan polysulfate
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[29] | |||
ICD Disease Classification 09 | Visual system disease | Click to Show/Hide | ||||
Acetazolamide
|
API Info |
Glaucoma [ICD-11: 9C61]
|
[30] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Amlodipine
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[31] | |||
Acebutolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[32] | |||
Disopyramide
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[33] | |||
Phenoxybenzamine
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[34] | |||
Quinapril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[35] | |||
ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
Omeprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[36] | |||
Esomeprazole
|
API Info |
Duodenal ulcer [ICD-11: DA63]
|
[37] | |||
Loperamide
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[38] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Celecoxib
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[39] | |||
Cyclosporin A
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[40] | |||
Rifampicin
|
API Info |
Osteoporosis [ICD-11: FB83]
|
[41] | |||
Fenoprofen
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[42] | |||
Tolmetin
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[43] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Terazosin
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[44] | |||
Tamsulosin
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[45] | |||
Prazosin
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[46] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Cytochrome P450 2E1 (CYP2E1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 141.2 uM (tested by experiment) | [47] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2E1_HUMAN | |||||
DBT Name: Cytochrome P450 2C9 (CYP2C9) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 = 249.5 uM (tested by experiment) | [47] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2C9_HUMAN | |||||
DBT Name: Mephenytoin 4-hydroxylase (CYP2C19) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 = 20.5 uM (tested by experiment) | [47] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2CJ_HUMAN | |||||
DBT Name: Debrisoquine 4-hydroxylase (CYP2D6) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | EC50 = 379.9 uM (tested by experiment) | [47] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2D6_HUMAN | |||||
Lyase/isomerase/ligase (L/I/G) | ||||||
DBT Name: Cholesterol 25-hydroxylase (CYP1A2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 40.9 uM (tested by experiment) | [47] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP1A2_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.